Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,258,907
+$3,403,633 QoQ
Shares Held
1,275,750
+2.3% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#81
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Dec 31, 2020CallValue
$2,061,400
CallShares
110,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,168,960 across 30 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
This page
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
35,697 | $6,016,371 |
All Filings in VTRS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,258,907 | 1,275,750 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,855,274 | 1,247,615 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $16,158,961 | 1,297,909 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $9,432,725 | 952,801 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,642,211 | 855,791 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $8,257,006 | 947,992 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $21,165,793 | 1,700,064 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $17,359,372 | 1,495,209 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $14,837,658 | 1,395,829 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,035,357 | 1,342,995 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $17,003,854 | 1,570,070 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $12,700,899 | 1,288,124 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $23,055,943 | 2,310,215 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $10,768,337 | 1,119,370 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $14,441,172 | 1,297,500 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $9,021,407 | 1,058,851 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $32,596,406 | 3,113,315 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $12,917,941 | 1,187,311 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $110,476,709 | 8,165,315 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $27,003,290 | 1,992,863 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $22,843,232 | 1,598,547 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $20,083,687 | 1,437,630 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,061,400 | 110,000 | Call | Defined | 2021-02-12 | |
| 2020-12-31 | $31,817,253 | 1,697,826 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||